Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001562180-23-001533 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-17 | 2023-02-15 | SNDX | Ordentlich Peter | CSO | M - OptEx | $6.95 | +25.0K | 17.4K | New | +$173.8K |
| DM | 2023-02-17 | 2023-02-15 | SNDX | Ordentlich Peter | CSO | S - Sale+OE | $25.84 | -25.0K | 0 | -100% | -$646.0K |
| DM | 2023-02-17 | 2023-02-15 | SNDX | Ordentlich Peter | CSO | M - OptEx | $25.84 | -25.0K | 0 | -100% | -$646.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | M | A | 7,572 | $6.38 | 7,572 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-15 | M | A | 17,428 | $7.20 | 17,428 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-15 | S | D | 7,572 | $25.84 | 0 | D | — | — | (F2) The sale prices ranged from $25.53 to $26.10. |
| 4 | Common | Common Stock | 2023-02-15 | S | D | 17,428 | $25.84 | 0 | D | — | — | (F2) The sale prices ranged from $25.53 to $26.10. |
| 5 | Derivative | Stock Options (Right to buy) | 2023-02-15 | M | D | 7,572 | $25.84 | 0 | D | $6.38 · — to 2029-02-06 | 7,572 Common Stock | (F3) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2023-02-15 | M | D | 17,428 | $25.84 | 0 | D | $7.20 · — to 2025-06-01 | 17,428 Common Stock | (F3) This option is fully vested. |